Stay updated on Pembrolizumab Skin Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Skin Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Skin Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision tag updated from v3.4.1 to v3.4.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedRevision: v3.4.1 replaces v3.4.0 as the page's version label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. No clinical trial content, eligibility criteria, or outcome measures appear to be altered.SummaryDifference0.1%

- Check62 days agoChange DetectedAdded a Locations section listing Georgia (Atlanta, Emory University/Winship Cancer Institute) as a study site. Removed the previous Georgia Locations heading and the HHS Vulnerability Disclosure link.SummaryDifference0.2%

- Check91 days agoChange DetectedThe page footer now displays Revision: v3.3.2, replacing the previous Revision: v3.2.0.SummaryDifference0.1%

- Check99 days agoChange DetectedA government funding lapse notice was removed from the page text, removing the informational banner about potential delays in processing and inquiries. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab Skin Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Skin Cancer Clinical Trial page.